XTL Biopharmaceuticals Ltd SEC filings XTLB
XTL Biopharmaceuticals Ltd has 546 filings in SEC EDGAR's recent list, going back to Nov 17, 2004. Its latest annual report, Form 20-F, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 14, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Notification of late filing | Apr 30, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Jun 7, 2021 | — |
| EFFECT | Filing | Mar 6, 2018 | — |
| CORRESP | Letter to the SEC | Mar 2, 2018 | — |
| D | Filing | Mar 29, 2017 | — |
| D | Filing | Mar 1, 2017 | — |
| CORRESP | Letter to the SEC | Nov 7, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2016 | — |
| EFFECT | Filing | Apr 4, 2014 | — |
| CORRESP | Letter to the SEC | Apr 3, 2014 | — |
| CORRESP | Letter to the SEC | Apr 2, 2014 | — |
| CORRESP | Letter to the SEC | Apr 2, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2014 | — |
| CERTNAS | Auto-generated paper document | Jul 12, 2013 | — |
| 8-A12B | Form 8-a12b | Jul 11, 2013 | — |
| CT ORDER | Filing | Jun 12, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2011 | — |
| CORRESP | Letter to the SEC | Feb 8, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2011 | — |
| CORRESP | Letter to the SEC | Jan 18, 2011 | — |
| CORRESP | Letter to the SEC | Jan 4, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2010 | — |
| 25-NSE | Delisting notice | Jul 10, 2009 | — |
| CT ORDER | Filing | Apr 22, 2009 | — |
| EFFECT | Filing | Sep 11, 2008 | — |
| EFFECT | Filing | Nov 20, 2007 | — |
| CORRESP | Letter to the SEC | Nov 16, 2007 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2007 | — |
| EFFECT | Filing | Mar 28, 2007 | — |
| EFFECT | Filing | May 22, 2006 | — |
| 20FR12G/A | Filing | Aug 29, 2005 | — |
| 20FR12G/A | Filing | Aug 23, 2005 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2005 | — |
| 20FR12G/A | Filing | Aug 10, 2005 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2005 | — |
| CORRESP | Letter to the SEC | Jul 14, 2005 | — |
| 20FR12G | Filing | Jul 14, 2005 | — |
| RW | Filing | Jul 7, 2005 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2005 | — |
| 20FR12G | Filing | May 12, 2005 | — |
| REGDEX | Auto-generated paper document | Nov 17, 2004 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XTLB (Nasdaq)
- Incorporated in
- Israel
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1023549
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.